Ropharma Bras (RPH) — Capital Reinvestment Ratio
Latest as of March 2023:
0.08x
Ropharma Bras (RPH) has a Capital Reinvestment Ratio of 0.08x as of March 2023, meaning it reinvests 0% of its operating cash flow (RON14.80 Million) in capital expenditures (RON1.20 Million). See how much free cash does Ropharma Bras generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.08x
Capex / Operating Cash Flow
Operating Cash Flow
RON14.80 Million
RON
Capital Expenditures
RON1.20 Million
RON
Data as of
Mar 2023
Most recent filing
Ropharma Bras Capital Reinvestment Ratio (2022–2025)
This chart tracks Ropharma Bras's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Ropharma Bras (2022–2025)
Year-by-year Capital Reinvestment Ratio for Ropharma Bras from 2022 to 2025. For live market cap and broader valuation context, see RPH stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (RON) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.43x | RON43.16 Million | RON18.74 Million | ▲ +8.8% |
| 2024 | 0.40x | RON40.49 Million | RON16.16 Million | ▼ -33.8% |
| 2023 | 0.60x | RON29.94 Million | RON18.06 Million | ▼ -74.4% |
| 2022 | 2.35x | RON14.65 Million | RON34.47 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow